A. Spyropoulou

Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.

I. Spiliopoulou, C. Bartzavali, M. Papadimitriou-Olivgeris, 2018, Diagnostic microbiology and infectious disease.

The first NDM metallo-β-lactamase producing Klebsiella pneumoniae isolate in a University Hospital of Southwestern Greece

I. Spiliopoulou, C. Bartzavali, A. Spyropoulou, 2016, Journal of chemotherapy.

A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.

I. Spiliopoulou, C. Bartzavali, M. Papadimitriou-Olivgeris, 2016, Journal of medical microbiology.

Flow resistive forces index (QRF): Development and clinical applicability assessment of a novel measure of bladder outlet resistance, aiming to enhance the diagnostic performance of uroflowmetry

D. Deligiannis, A. Spyropoulou, D. Kotsiris, 2020, Lower urinary tract symptoms.

Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality

V. Karamouzos, I. Spiliopoulou, C. Bartzavali, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

Risk factors and predictors of carbapenem‐resistant Pseudomonas aeruginosa and Acinetobacter baumannii mortality in critically ill bacteraemic patients over a 6‐year period (2010‐15): antibiotics do matter

F. Kolonitsiou, I. Spiliopoulou, M. Papadimitriou-Olivgeris, 2017, Journal of Medical Microbiology.